---
created: 2025-04-13
updated: 2025-04-13T10:52
id: Ge%|@]`$m2
specialty: pharmaco
specialty_id: 234
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::03-hypercoagulable-states
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::07-anticoagulants
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::03-toxicities-&-side-effects::05-drug-reactions---hematologic
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::03-warfarin
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::13-hematology-oncology::11-hemostasis
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::17-hem/onc-pharm::warfarin
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::10-heme::warfarin
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::01-anticoagulants-&-thrombolytics::02-warfarin
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::1000-1999::1088
  - source/ak-step1-v11::^other::^highyield::1-highyield"
type: flashcard
---

# Question
What warfarin complication presents a few days after beginning treatment due to an early transient hypercoagulable state?   **Warfarin-induced skin necrosis**

---

# Answer
besides 2, 7, 9 and 10, it also decreases decarboxylation of proteins C and S, which exert anticoagulant effect through proteolysis and deactivation of factor V and VIII   Skin tissue necrosis within first few days of large doses believed to be due to small vessel microthrombosis.